Axcelis Technologies, Inc. — FY 2016 Form 10-K
Reporting period: Fiscal year ended December 31, 2016. This is an annual filing, not a standalone Q4 report; the filing also provides unaudited fourth-quarter results. Amounts are in U.S. dollars.
Business context and reporting period
Axcelis designs, manufactures and services ion implantation and other semiconductor processing equipment. Ion implantation accounted for 93.2% of FY 2016 revenue; aftermarket products and services include spare parts, upgrades, used tools and maintenance. The company operates in one business segment and sells primarily to semiconductor manufacturers worldwide.
Management described 2016 as challenging, citing reduced purchases from key memory customers, particularly in DRAM. Axcelis continued investing in its Purion platform, introduced product extensions and placed Purion systems with seven new customers and in seven additional fabs of existing customers.
Financial performance and liquidity
| Metric | FY 2016 | FY 2015 |
|---|---|---|
| Revenue | $267.0 million | $301.5 million |
| Gross profit / margin | $99.6 million / 37.3% | $101.7 million / 33.7% |
| Operating income / margin | $16.6 million / 6.2% | $20.7 million / 6.9% |
| Net income | $11.0 million | $14.7 million |
| Diluted EPS | $0.36 | $0.49 |
| Cash from operating activities | $(8.8) million | $18.3 million |
| Capital expenditures | $2.5 million | $1.8 million |
FY 2016 product revenue fell 12.4% to $244.3 million; services revenue was essentially flat at $22.7 million. Product gross margin rose to 39.0% from 35.1%, which management attributed to supply-chain optimization, value engineering, lean operations and a richer mix of parts and upgrades. Services gross margin increased to 19.0% from 17.2%.
Fourth-quarter 2016 revenue was $69.4 million, gross profit $26.9 million and net income $4.0 million, versus $70.5 million, $22.0 million and $0.8 million, respectively, in Q4 2015. Diluted EPS was $0.13 in Q4 2016 and $0.03 in Q4 2015.
Cash and cash equivalents were $70.8 million at year-end, down from $78.9 million; working capital was $193.0 million. The company reported no bank debt and held $6.9 million of restricted cash. The 2015 headquarters sale-leaseback is accounted for as financing: the balance-sheet obligation was $47.6 million, with $125.9 million of future contractual payments, including $78.4 million of interest. Operating cash flow turned negative in 2016, with working-capital movements including increased receivables and inventory contributing to the use of cash.
Material changes versus prior period
- Revenue declined 11.4% year over year, mainly due to fewer Purion system sales following weaker DRAM customer spending.
- Gross margin improved 3.6 percentage points, but operating income and net income fell as lower revenue and higher operating expenses offset margin gains. R&D expense rose to $34.4 million, or 12.9% of revenue.
- Operating cash flow decreased by $27.1 million, from $18.3 million provided in 2015 to $8.8 million used in 2016.
- Systems backlog, including deferred systems revenue, was $17.5 million at year-end versus $22.5 million a year earlier; Q4 bookings increased to $34.8 million from $26.1 million.
- Aftermarket revenue decreased modestly to $127.7 million from $129.6 million. The top ten customers generated 70.2% of revenue versus 76.8% in 2015; one customer represented 17.0% in 2016.
Outlook, risks and unusual items
Management expected Purion customer adoption and demand to continue growing and said it expected consistent, profitable performance in 2017. Strategic priorities included increasing Purion market share and aftermarket revenue, improving gross margins, and enhancing profitability and cash generation. Planned 2017 capital expenditures were approximately $7.5 million. No quantified revenue or earnings guidance was provided.
Key risks include semiconductor capital-spending cyclicality, reliance on a limited number of large customers, intense competition, international exposure, supplier constraints, product development and acceptance, and dependence on aftermarket purchases. International revenue was 80.0% of FY 2016 revenue. Orders and backlog may be canceled or rescheduled, and reported results can fluctuate with shipment timing and customer acceptance.
Notable items include a $0.3 million restructuring charge in 2016 and a $0.6 million Q4 inventory-reserve charge. The company corrected a prior-period accounting error that had overstated 2015 inventory and equity by $6.5 million; management said it was not material to any previously reported period and it did not affect consolidated operating results or cash flows after 2010. A 1-for-4 reverse stock split took effect June 30, 2016; per-share data in the filing is adjusted accordingly. The company maintains a full valuation allowance against U.S. deferred tax assets. Ernst & Young issued unqualified opinions on the financial statements and internal control over financial reporting; management also concluded disclosure controls were effective.
The filing identifies no litigation believed likely to have a material adverse effect and no pending environmental matter expected to have a material business impact. It discloses normal-course litigation, customer IP indemnification obligations, and cybersecurity and foreign-exchange risks.
Important facts for investors to verify
- Whether memory-sector and DRAM spending recover, and whether Purion placements convert into repeat orders and revenue.
- Whether gross-margin improvement is sustainable while revenue remains below 2015 levels.
- Drivers of negative operating cash flow, and whether receivables and inventory normalize; year-end inventory was $113.9 million.
- Customer concentration, year-end backlog and the extent of potential order cancellations or shipment delays.
- The cash-flow and long-term financial burden of the sale-leaseback, alongside the company’s reported lack of bank debt.
- Potential realization of tax assets: U.S. deferred tax assets remain fully reserved, and tax-loss and credit carryforwards have stated expiration periods.